 |
| |
| Apr-03-18 | Upgrade |
Raymond James |
Mkt Perform → Outperform |
|
|
| Jan-05-18 | Downgrade |
Craig Hallum |
Buy → Hold |
|
|
| Apr-07-17 | Reiterated |
Cantor Fitzgerald |
Overweight |
$20 → $21 |
|
| Mar-30-17 | Downgrade |
KeyBanc Capital Mkts |
Overweight → Sector Weight |
|
|
| Feb-08-17 | Initiated |
Barclays |
Equal Weight |
$17 |
|
| Nov-04-16 | Initiated |
Cantor Fitzgerald |
Buy |
|
|
| Apr-08-16 | Resumed |
Piper Jaffray |
Neutral |
|
|
| Jan-08-16 | Reiterated |
Canaccord Genuity |
Buy |
$17.50 → $14.50 |
|
| Nov-10-15 | Downgrade |
Raymond James |
Outperform → Mkt Perform |
|
|
| Jul-24-15 | Initiated |
KeyBanc Capital Mkts |
Overweight |
|
|
| Jun-19-14 | Upgrade |
Canaccord Genuity |
Hold → Buy |
$16.25 → $20 |
|
| Oct-09-12 | Reiterated |
Canaccord Genuity |
Hold |
$14 → $13.50 |
|
| Jun-25-12 | Downgrade |
Canaccord Genuity |
Buy → Hold |
$16.50 → $14.50 |
|
| Jul-15-11 | Upgrade |
Stifel Nicolaus |
Hold → Buy |
$16.50 |
|
| Jul-15-11 | Upgrade |
Canaccord Genuity |
Hold → Buy |
$15 → $16.50 |
|
| Jun-14-11 | Downgrade |
Wedbush |
Neutral → Underperform |
$14 → $12 |
|
| Sep-08-10 | Reiterated |
Wedbush |
Neutral |
$17.50 → $14 |
|
| Mar-04-10 | Initiated |
Wedbush Morgan |
Neutral |
$17.50 |
|
| Sep-04-09 | Reiterated |
Caris & Company |
Above Average |
$13 → $15 |
|
| Jul-17-09 | Reiterated |
Caris & Company |
Above Average |
$15 → $13 |
|
|
|
| Jan-14-19 10:03PM | Edited Transcript of ANGO earnings conference call or presentation 4-Jan-19 1:00pm GMT Thomson Reuters StreetEvents |
| Jan-07-19 08:14PM | AngioDynamics (ANGO) Q2 2019 Earnings Conference Call Transcript Motley Fool |
| 09:35AM | AngioDynamics (ANGO) Q2 Earnings Beat on Gains From NanoKnife Zacks |
| 07:43AM | Oncology business propels AngioDynamics to $91.5 million second quarter American City Business Journals |
| Jan-04-19 08:25AM | AngioDynamics (ANGO) Beats Q2 Earnings and Revenue Estimates Zacks +10.76% |
| 07:18AM | AngioDynamics: Fiscal 2Q Earnings Snapshot Associated Press |
| 07:00AM | AngioDynamics Reports Fiscal 2019 Second Quarter Financial Results Business Wire |
| Dec-28-18 10:30AM | AngioDynamics (ANGO) Earnings Expected to Grow: What to Know Ahead of Next Week's Release Zacks |
| Dec-20-18 04:01PM | AngioDynamics to Present at the J.P. Morgan Healthcare Conference Business Wire |
| Dec-19-18 02:59PM | What Does AngioDynamics, Inc.s (NASDAQ:ANGO) P/E Ratio Tell You? Simply Wall St. |
| Dec-10-18 04:01PM | AngioDynamics to Report Fiscal 2019 Second Quarter Financial Results on January 4, 2019 Business Wire |
| Nov-13-18 02:54PM | Can AngioDynamics Inc (NASDAQ:ANGO) Improve Its Returns? Simply Wall St. |
| Oct-27-18 09:30AM | AngioDynamics (ANGO) Down 6.9% Since Last Earnings Report: Can It Rebound? Zacks |
| Oct-16-18 08:40AM | Consolidated Research: 2018 Summary Expectations for Mimecast, Shiloh Industries, Adverum Biotechnologies, AngioDynamics, Kimball Electronics, and Changyou Fundamental Analysis, Key Performance Indications GlobeNewswire |
| Oct-02-18 03:53PM | What does AngioDynamics Incs (NASDAQ:ANGO) Balance Sheet Tell Us About Its Future? Simply Wall St. |
| Oct-01-18 09:31AM | AngioDynamics (ANGO) Q1 Earnings Miss, '19 Sales View Up Zacks |
| Sep-28-18 01:11AM | Edited Transcript of ANGO earnings conference call or presentation 27-Sep-18 12:00pm GMT Thomson Reuters StreetEvents |
| Sep-27-18 08:25AM | AngioDynamics (ANGO) Lags Q1 Earnings Estimates Zacks -10.85% |
| 07:21AM | AngioDynamics: Fiscal 1Q Earnings Snapshot Associated Press |
| 07:00AM | AngioDynamics Reports Fiscal 2019 First Quarter Financial Results Business Wire |
| Sep-20-18 10:30AM | AngioDynamics (ANGO) Q1 Earnings Preview: What to Watch Ahead of the Release Zacks |
| 07:56AM | What's in Store for AngioDynamics (ANGO) in Q1 Earnings? Zacks |
| Sep-19-18 04:01PM | AngioDynamics to Present at the Cantor Global Healthcare Conference Business Wire |
| 08:44AM | Here's Why You Should Hold AngioDynamics' (ANGO) Stock Now Zacks |
| Sep-14-18 02:34PM | AngioDynamics (ANGO) to Acquire RadiaDyne, Boost Oncology Zacks |
| 08:16AM | AngioDynamics expands oncology business with acquisition of Houston co. American City Business Journals |
| Sep-13-18 04:01PM | AngioDynamics to Report Fiscal 2019 First Quarter Financial Results on September 27, 2018 Business Wire |
| 07:00AM | AngioDynamics to Acquire RadiaDyne and its Revolutionary OARtrac® Radiation Dose Monitoring Platform to Further Expand Oncology Portfolio Business Wire |
| Sep-07-18 07:45AM | New Strong Sell Stocks for September 7th Zacks |
| Sep-02-18 10:12AM | How Should You Think About AngioDynamics Incs (NASDAQ:ANGO) Risks? Simply Wall St. |
| Aug-23-18 04:01PM | AngioDynamics to Present at Two Investor Conferences in September Business Wire |
| 08:40AM | New Strong Sell Stocks for August 23rd Zacks |
| Aug-21-18 06:44AM | New Strong Sell Stocks for August 21st Zacks |
| Aug-17-18 07:55AM | Factors of Influence in 2018, Key Indicators and Opportunity within Okta, Great Lakes Dredge & Dock, MDC Partners, Colfax, Heritage-Crystal Clean, and AngioDynamics New Research Emphasizes Economic Growth GlobeNewswire |
| Aug-16-18 09:22AM | AngioDynamics' (ANGO) BioSentry Buyout to Boost Oncology Zacks |
| Aug-15-18 07:00AM | AngioDynamics Provides Updates on Oncology and Vascular Access Businesses Business Wire |
| Aug-10-18 10:06AM | Why Is AngioDynamics (ANGO) Up 5.02% Since Its Last Earnings Report? Zacks |
| Jul-30-18 09:05AM | Align, AngioDynamics and Caterpillar highlighted as Zacks Bull and Bear of the Day Zacks |
| 07:00AM | Bear of the Day: AngioDynamics (ANGO) Zacks |
| Jul-19-18 10:37AM | Medical device company settles US case over false claims Associated Press |
| 10:36AM | Medical device company settles US case over false claims Associated Press |
| Jul-18-18 05:26PM | AngioDynamics to pay $12.5 mln over false claims allegations -U.S. Justice Dept Reuters |
| 07:00AM | Free Post Earnings Research Report: AngioDynamics' Revenues Improved 1.6%; Adjusted EPS Advanced 5.3% ACCESSWIRE |
| Jul-17-18 08:13AM | AngioDynamics (ANGO) Q4 Performance Dull, Competition Rife Zacks |
| Jul-12-18 08:46AM | AngioDynamics (ANGO) Misses Q4 Earnings & Revenue Estimates Zacks +8.18% |
| 02:52AM | Edited Transcript of ANGO earnings conference call or presentation 11-Jul-18 12:00pm GMT Thomson Reuters StreetEvents |
| Jul-11-18 08:37AM | AngioDynamics (ANGO) Misses Q4 Earnings and Revenue Estimates Zacks -16.08% |
| 07:12AM | AngioDynamics: Fiscal 4Q Earnings Snapshot Associated Press |
| 07:00AM | AngioDynamics Reports Fiscal 2018 Fourth Quarter and Full-Year Financial Results Business Wire |
| 06:00AM | AngioDynamics, Inc. to Host Earnings Call ACCESSWIRE |
| Jul-10-18 02:33PM | Earnings Preview For AngioDynamics Benzinga |
| Jul-02-18 08:03AM | What's in Store for AngioDynamics (ANGO) in Q4 Earnings? Zacks |
| Jun-24-18 09:23AM | Estimating The Intrinsic Value Of AngioDynamics Inc (NASDAQ:ANGO) Simply Wall St. |
| Jun-21-18 04:01PM | AngioDynamics to Report Fiscal 2018 Fourth Quarter and Full-Year Financial Results on July 11, 2018 Business Wire |
| May-29-18 08:15AM | Research Report Identifies AngioDynamics, Kaiser Aluminum, Mammoth Energy Services, Meridian Bioscience, Merrimack Pharmaceuticals, and Energizer with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire |
| Apr-30-18 01:45AM | Why Is AngioDynamics (ANGO) Up 13.9% Since Its Last Earnings Report? Zacks |
| Apr-10-18 04:01PM | AngioDynamics to Present at Two Investor Conferences in May Business Wire |
| Apr-05-18 07:20AM | Blog Exposure - Waters Corp. to Significantly Expand its Precision Chemistry Facility in Massachusetts ACCESSWIRE |
| Apr-04-18 08:20AM | Recent Analysis Shows Multi-Color, Madrigal Pharmaceuticals, SPX, AngioDynamics, Atara Biotherapeutics, and Quanex Building Products Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire |
| Apr-03-18 10:25AM | AngioDynamics (ANGO) Product Line Strong, Debt Level High Zacks +5.57% |
| Apr-02-18 10:15AM | AngioDynamics (ANGO) Beats on Q3 Earnings, Reiterates View Zacks |
| Apr-01-18 10:10AM | AngioDynamics (ANGO) Q3 2018 Earnings Conference Call Transcript Motley Fool |
| Mar-29-18 07:25PM | Edited Transcript of ANGO earnings conference call or presentation 29-Mar-18 12:00pm GMT Thomson Reuters StreetEvents |
| 07:59AM | Where AngioDynamics Inc (NASDAQ:ANGO) Stands In Earnings Growth Against Its Industry Simply Wall St. |
| 07:12AM | AngioDynamics misses 3Q revenue forecasts Associated Press |
| 07:00AM | AngioDynamics Reports Fiscal 2018 Third Quarter Financial Results Business Wire |
| 06:00AM | AngioDynamics, Inc. to Host Earnings Call ACCESSWIRE |
| Mar-15-18 04:01PM | AngioDynamics to Present at the Needham 17th Annual Healthcare Conference Business Wire |
| Feb-27-18 04:01PM | AngioDynamics to Report Fiscal 2018 Third Quarter Financial Results on March 29, 2018 Business Wire |
| Feb-15-18 08:00AM | AngioDynamics to Present at the Barclays Global Healthcare Conference Business Wire |
| Feb-06-18 08:00AM | Investor Expectations to Drive Momentum within Regal Beloit, Kaiser Aluminum, AngioDynamics, Mulesoft, Assembly Biosciences, and Woodward Discovering Underlying Factors of Influence GlobeNewswire |
| Jan-26-18 10:56AM | AngioDynamics Receives FDA Nod, to Treat Pancreatic Cancer Zacks |
| Jan-25-18 07:30AM | Free Post Earnings Research Report: Waters Sales Jumped 9%; Adjusted EPS Surged 14% ACCESSWIRE |
| Jan-24-18 04:01PM | AngioDynamics Receives FDA Expedited Access Pathway Designation for the NanoKnife® System for the Treatment of Stage III Pancreatic Cancer Business Wire |
| 07:59AM | AngioDynamics (ANGO) Banks on Buyouts, Debt Level High Zacks |
| Jan-19-18 10:55AM | AngioDynamics, Inc. :ANGO-US: Earnings Analysis: Q2, 2018 By the Numbers : January 19, 2018 Capital Cube |
| Jan-10-18 09:05AM | Zacks.com featured highlights include: AngioDynamics, Zumiez, GP Strategies, AngloGold and Raymond James Zacks |
| Jan-09-18 07:42AM | Bet on These 5 PEG-Ratio Based GARP Picks Zacks |
| Jan-05-18 03:30PM | AngioDynamics (ANGO) Misses on Earnings, Revenues in Q2 Zacks |
| Jan-04-18 08:45PM | Edited Transcript of ANGO earnings conference call or presentation 4-Jan-18 1:00pm GMT Thomson Reuters StreetEvents |
| 07:11AM | AngioDynamics misses Street 2Q forecasts Associated Press |
| 07:00AM | AngioDynamics Reports Fiscal 2018 Second Quarter Financial Results Business Wire |
| Jan-03-18 01:37PM | Can AngioDynamics (ANGO) Pull a Surprise in Q2 Earnings? Zacks |
| Dec-28-17 11:48AM | ETFs with exposure to AngioDynamics, Inc. : December 28, 2017 Capital Cube |
| Dec-19-17 04:01PM | AngioDynamics to Present at the J.P. Morgan Healthcare Conference Business Wire |
| Dec-15-17 08:00AM | AngioDynamics, Inc. breached its 50 day moving average in a Bearish Manner : ANGO-US : December 15, 2017 Capital Cube |
| Dec-11-17 04:01PM | AngioDynamics to Report Fiscal 2018 Second Quarter Financial Results on January 4, 2018 Business Wire |
| Dec-05-17 07:47AM | AngioDynamics, Inc. breached its 50 day moving average in a Bearish Manner : ANGO-US : December 5, 2017 Capital Cube |
| Nov-24-17 11:12AM | AngioDynamics, Inc. Value Analysis (NASDAQ:ANGO) : November 24, 2017 Capital Cube |
| Nov-22-17 07:30AM | AngioDynamics, Inc. breached its 50 day moving average in a Bullish Manner : ANGO-US : November 22, 2017 Capital Cube |
| Oct-30-17 04:11AM | Why Is AngioDynamics (ANGO) Up 5.3% Since the Last Earnings Report? Zacks |
| Oct-27-17 10:43AM | ETFs with exposure to AngioDynamics, Inc. : October 27, 2017 Capital Cube |
| Oct-17-17 08:05AM | AngioDynamics, Inc. breached its 50 day moving average in a Bullish Manner : ANGO-US : October 17, 2017 Capital Cube |
| Oct-11-17 07:40AM | Earnings Review and Free Research Report: AngioDynamics Reported Lower than Expected Quarterly Results ACCESSWIRE |
| Oct-04-17 10:31AM | ETFs with exposure to AngioDynamics, Inc. : October 4, 2017 Capital Cube |
| 08:51AM | AngioDynamicis' (ANGO) Solero MTA System to Drive Growth Zacks |
| 07:00AM | Earnings Review and Free Research Report: Lakelands Revenue Jumped 7.4%; EPS Surged 25% ACCESSWIRE |
| Oct-03-17 09:43AM | AngioDynamics, Inc. :ANGO-US: Earnings Analysis: Q1, 2018 By the Numbers : October 3, 2017 Capital Cube |
| 07:00AM | Corporate News Blog - Skyline Medical Provides Update on Pending CytoBioscience Merger ACCESSWIRE |
| Oct-02-17 11:14AM | AngioDynamics, Inc. Value Analysis (NASDAQ:ANGO) : October 2, 2017 Capital Cube |
|
|
|
|
| AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices for the treatment of peripheral vascular disease, vascular access, and for use in oncology and surgical settings in the United States and internationally. The company provides AngioVac venous drainage system that includes venous drainage cannula for the removal of fresh, soft thrombi, or emboli during extracorporeal bypass; and cardiopulmonary bypass circuit for use in procedures during extracorporeal circulatory support. It also offers thrombolytic catheters to deliver thrombolytic agents; angiographic products and accessories for use in during peripheral vascular interventional procedures; drainage products, which drain abscesses and other fluid pockets; and micro access sets. In addition, the company provides manifolds, contrast management systems, closed fluid systems, guidewires, disposable transducers, and interventional accessories that help clinicians in the diagnosis and treatment of cardiovascular and peripheral vascular diseases; VenaCure EVLT laser system products to treat superficial venous diseases; and Asclera injection for treating uncomplicated spider and reticular veins of the lower extremities. Further, it provides NanoKnife ablation systems for the surgical ablation of soft tissues; solero microwave tissue ablation system; and radiofrequency ablation products for ablating solid cancerous or benign tumors. Additionally, the company offers peripherally inserted central catheters, midline catheters, implantable ports, dialysis catheters, and related accessories and supplies. It sells and markets its products to interventional radiologists, interventional cardiologists, vascular surgeons, urologists, interventional and surgical oncologists, and critical care nurses directly, as well as through distributor relationships. The company was founded in 1988 and is headquartered in Latham, New York. |
|
| Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
| Greiner Michael | EVP and CFO | Nov 07 | Sale | 21.53 | 1,939 | 41,747 | 20,731 | Nov 08 04:06 PM | | Trowbridge Stephen A | SVP and General Counsel | Jul 12 | Option Exercise | 0.00 | 3,556 | 0 | 40,110 | Aug 22 07:05 PM | | GOLD JEFFREY | Director | Jul 06 | Option Exercise | 13.53 | 7,000 | 94,710 | 70,906 | Jul 10 06:44 PM | | JOHNSON WESLEY | Director | Jun 22 | Option Exercise | 13.53 | 14,000 | 189,420 | 60,974 | Jun 25 04:20 PM | | Meteny Dennis S | Director | Jun 21 | Option Exercise | 13.53 | 14,000 | 189,420 | 83,127 | Jun 25 04:30 PM | | DONNELLY HOWARD W | Director | Jun 21 | Option Exercise | 10.68 | 6,650 | 71,022 | 65,353 | Jun 25 04:26 PM | | GOLD JEFFREY | Director | Jun 21 | Option Exercise | 13.53 | 7,000 | 94,710 | 68,134 | Jun 25 04:23 PM |
|
|
|
|
|
|
